Cargando…
Thiazide Use and Decreased Risk of Heart Failure in Nondiabetic Patients Receiving Intensive Blood Pressure Treatment
The SPRINT (Systolic Blood Pressure Intervention Trial) study reported that intensive blood pressure (BP) treatment with a systolic BP target of <120 mm Hg decreased the risks of cardiovascular events. However, it remains unknown whether specific medications can further improve cardiovascular out...
Autores principales: | Tsujimoto, Tetsuro, Kajio, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott, Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340223/ https://www.ncbi.nlm.nih.gov/pubmed/32639892 http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.15154 |
Ejemplares similares
-
Thiazide Use and Cardiovascular Events in Type 2 Diabetic Patients With Well-Controlled Blood Pressure
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019) -
Intensive Blood Pressure Treatment for Resistant Hypertension: Secondary Analysis of a Randomized Controlled Trial
por: Tsujimoto, Tetsuro, et al.
Publicado: (2019) -
Beta-blocker use and cardiovascular event risk in patients with heart failure with preserved ejection fraction
por: Tsujimoto, Tetsuro, et al.
Publicado: (2018) -
Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension
por: Tsujimoto, Tetsuro, et al.
Publicado: (2020) -
Effects of β‐blockers on all‐cause mortality in patients with type 2 diabetes and coronary heart disease
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)